Saudi Arabia Acromegaly Treatment Market Size & Outlook
Related Markets
Saudi Arabia acromegaly treatment market highlights
- The Saudi Arabia acromegaly treatment market generated a revenue of USD 10.9 million in 2024 and is expected to reach USD 15.4 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 6% from 2025 to 2030.
- In terms of segment, somatostatin analogues (ssas) was the largest revenue generating drug class in 2024.
- Other Drug Types is the most lucrative drug class segment registering the fastest growth during the forecast period.
Acromegaly treatment market data book summary
| Market revenue in 2024 | USD 10.9 million |
| Market revenue in 2030 | USD 15.4 million |
| Growth rate | 6% (CAGR from 2025 to 2030) |
| Largest segment | Somatostatin analogues (ssas) |
| Fastest growing segment | Other Drug Types |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Somatostatin Analogues (SSAs), Growth Hormone Receptor Antagonists (GHRAs), Dopamine Agonists, Other Drug Types |
| Key market players worldwide | Novartis AG ADR, Ipsen SA, Sun Pharmaceutical Industries, Wockhardt, Dauntless Pharmaceuticals, Pfizer Inc, Ionis Pharmaceuticals Inc |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.7% of the global acromegaly treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa acromegaly treatment market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 16.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Acromegaly Treatment Market Scope
Acromegaly Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Peptron | View profile | 11-50 | Yusong, Taejon-jikhalsi, South Korea, Asia | http://www.peptron.co.kr |
| Chiasma | View profile | 51-100 | Needham, Massachusetts, United States, North America | https://chiasma.com |
| Dauntless Pharmaceuticals | View profile | 11-50 | San Diego, California, United States, North America | http://www.dauntlessph.com/ |
| Wockhardt | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://wockhardt.com |
| Ipsen SA | View profile | 5325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | https://www.ipsen.com |
| Ionis Pharmaceuticals Inc | View profile | 927 | 2855 Gazelle Court, Carlsbad, CA, United States, 92010 | https://www.ionispharma.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Saudi Arabia acromegaly treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to acromegaly treatment market will help companies and investors design strategic landscapes.
Somatostatin analogues (ssas) was the largest segment with a revenue share of 65.14% in 2024. Horizon Databook has segmented the Saudi Arabia acromegaly treatment market based on somatostatin analogues (ssas), growth hormone receptor antagonists (ghras), dopamine agonists, other drug types covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Saudi Arabia acromegaly treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia acromegaly treatment market databook
-
Our clientele includes a mix of acromegaly treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia acromegaly treatment market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia acromegaly treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia acromegaly treatment market size, by drug class, 2018-2030 (US$M)
Saudi Arabia Acromegaly Treatment Market Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
